A detailed history of Cito Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 23,256 shares of MRK stock, worth $2.36 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
23,256
Previous 23,256 -0.0%
Holding current value
$2.36 Million
Previous $3.08 Million 6.13%
% of portfolio
1.12%
Previous 1.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $339,720 - $395,849
3,000 Added 14.81%
23,256 $3.08 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $41,180 - $45,732
400 Added 2.01%
20,256 $2.1 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $7,519 - $9,641
86 Added 0.44%
19,856 $2.21 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $166,980 - $189,280
-2,000 Reduced 9.19%
19,770 $1.82 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $14,456 - $18,108
200 Added 0.93%
21,770 $1.68 Million
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $501,760 - $551,810
7,000 Added 48.04%
21,570 $1.63 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $26,577 - $29,397
-378 Reduced 2.53%
14,570 $1.14 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $6,886 - $8,111
-100 Reduced 0.66%
14,948 $1.16 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $5,454 - $6,053
-76 Reduced 0.5%
15,048 $1.24 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $292,849 - $405,904
-4,622 Reduced 23.41%
15,124 $1.17 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $38,790 - $43,770
-500 Reduced 2.47%
19,746 $1.8 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $67,178 - $73,227
-883 Reduced 4.18%
20,246 $1.71 Million
Q2 2018

Jul 03, 2018

SELL
$50.83 - $59.72 $508,300 - $597,200
-10,000 Reduced 32.12%
21,129 $1.29 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $1.83 Million - $1.97 Million
31,129
31,129 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cito Capital Group, LLC Portfolio

Follow Cito Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.